This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Toshimasa Harumoto
Introduction
Toshimasa Harumoto is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. With a total of two patents to his name, Harumoto's work showcases his expertise and innovative spirit.
Latest Patents
Harumoto's latest patents include a nucleic acid conjugate and a bispecific antibody. The nucleic acid conjugate involves a sugar chain ligand bonded to an oligonucleotide via a linker, featuring O-bonded mannose at its non-reducing end. This invention has potential applications in targeted drug delivery and gene therapy. The bispecific antibody is designed to bind to CD116 and CD131, providing agonist activity to a GM-CSF receptor. This invention includes a first antigen-binding domain and a second antigen-binding domain, enhancing its therapeutic potential.
Career Highlights
Harumoto is currently employed at Kyowa Kirin Co., Ltd., a leading biopharmaceutical company. His work at the company focuses on advancing innovative treatments for various diseases. His contributions have been instrumental in the development of new therapeutic strategies.
Collaborations
Some of Harumoto's coworkers include Akifumi Kato and Harue Nishiya. Their collaborative efforts contribute to the innovative environment at Kyowa Kirin Co., Ltd.
Conclusion
Toshimasa Harumoto's inventions reflect his dedication to advancing biotechnology. His patents demonstrate the potential for significant advancements in therapeutic applications. His work continues to inspire innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile